Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al
Reported side effects are minimal, but some users in experimental settings have described: Mild fatigue Temporary nausea Headache or dizziness Long-Term Risks The long-term impact of MOTS-c therapy remains unknown, raising concerns about possible risks from prolonged use: Metabolic Overstimulation: chronic AMPK activation may interfere with natural energy signaling
LPS expressed by G- dysbiotic colonies both initiates and activates the NLRP3 inflammasome and leads to downstream production of IL-1 and IL-18
This helps control hunger, boost energy, and even improve mood
Injections are typically given two to three times per week , though schedules vary depending on the peptide and treatment goals